Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6820167 | 0.81 | TDP1 (0.44) | ERN1ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL1414921 | 0.79 | ERN1 (1.00) | ERN1ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL6819375 | 0.78 | ERN1 (0.59) | ERN1ALDH1A1MEN1KMT2ANCEH1 | |
| SCHEMBL24215332 | 0.75 | CYP2A6 (0.50) | ERN1ALDH1A1MEN1KMT2ANCEH1 | |
| SCHEMBL38663463 | 0.75 | ERN1 (0.59) | ERN1ALDH1A1MEN1KMT2ACYP2A6 | |
| SCHEMBL3008338 | 0.75 | ERN1 (0.59) | ERN1ALDH1A1MEN1KMT2ANCEH1 | |
| SCHEMBL15577736 | 0.75 | ERN1 (0.51) | ERN1ALDH1A1NCEH1CYP2A6 | |
| SCHEMBL28948948 | 0.75 | CYP1A2 (0.43) | ERN1ALDH1A1CYP2A6KDM4EMAPT | |
| SCHEMBL30067006 | 0.75 | ERN1 (0.59) | ERN1ALDH1A1MEN1KMT2ANCEH1 | |
| SCHEMBL1246034 | 0.73 | ERN1 (0.60) | ERN1ALDH1A1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843853-B | Composition and method for manufacturing device using the same | 东洋合成工业株式会社 | 2022-09-20 | — | — | CN | disclosed |
| US-11142495-B2 | Composition and method for manufacturing device using same | TOYO GOSEI CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20200048191-A1 | COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME | TOYO GOSEI CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048191-A1 | COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME | LBR, LMTK2, MMS19 | ERN1 915/4885ALDH1A1 4785/4885MEN1 3312/4885 |
| US-11142495-B2 | Composition and method for manufacturing device using same | LBR, LMTK2, MMS19 | ERN1 915/4885ALDH1A1 4785/4885MEN1 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.